CVS Health is launching a new company that will work directly with drug makers to produce and commercialize “biosimilar” drugs, the less expensive versions of expensive brand prescriptions derived from biotechnology.
Biosimilars are versions of biologic medicines approved by the U.S. Food and Drug Adminstration that are “highly similar to” and have “no clinically meaningful differences from” brand biologic medicines already on the market, CVS said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: